Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of a common cold treatment on cognitive function
2010-022857-41Phase 4Completed
- Sponsor
- GSK
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of paracetamol + caffeine in nasopharyngitis, sponsored by GSK. Primary endpoint: Change in alertness level at 30 minutes post-dosing. Started Oct 2010; status: completed.
02
Drugs
paracetamol + caffeine
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on 2010-022857-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022857-41.